[{"Assets_0_Q2_USD":642307000.0,"CommonStockSharesOutstanding_0_Q2_shares":101272000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":133151000.0,"StockholdersEquity_0_Q2_USD":226683000.0,"EarningsPerShareBasic_1_Q2_USD":0.37,"EarningsPerShareBasic_2_Q2_USD":0.71,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":101151000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":101105000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190724"}]